-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.67167% Upside
Lucid Diagnostics Inc. Frequently Asked Questions
-
What analysts cover Lucid Diagnostics Inc.?
Lucid Diagnostics Inc. has been rated by research analysts at Needham, Canaccord Genuity, BTIG in the past 90 days.